Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the triglyceride changes in subjects with type 2
diabetes mellitus taking pioglitazone, once daily (QD), following treatment conversion from
rosiglitazone.